Answers to Frequently
Asked Questions about
Using QVAR®

When do I use the QVAR® inhaler?

Always take QVAR® as your doctor has prescribed. The usual regimen is twice a day. To help you remember, try taking QVAR® along with other daily activities, like brushing your teeth in the morning and at night, or while taking other "twice daily" medications. QVAR®'s built-in dose counter will also help you keep track of how many doses you have left.

What do I need to know about using other medications while using QVAR®?

Make sure your healthcare provider knows about all the medications you are taking, as well as any dietary supplements or herbal remedies that you may be using. Your doctor may adjust your dose of QVAR® or other medications depending on how they interact.

What are common side effects of QVAR®?

In clinical trials, the most common side effects of QVAR® were headache, sore throat and sinus irritation. These are not all the possible side effects of QVAR®. If any side effects occur, you should talk to your healthcare provider. Please review all of the Important Safety Information.

Is QVAR® the same as combination products?

Some asthma medications contain a combination of an ICS (inhaled corticosteroid) and a LABA (long-acting beta agonist). QVAR® is different from combination products because there is only one drug in QVAR®, an ICS. QVAR® is a part of a class of medications that doctors often prescribe first for treating mild-to-moderate persistent asthma. According to The National Heart, Lung, and Blood Institute Expert Panel Report 3, ICS medications are the preferred therapy available for patients with mild-to-moderate persistent asthma.1

Learn about combination inhalers.

Approved Uses
QVAR® (beclomethasone dipropionate HFA) Inhalation Aerosol is used in the ongoing treatment of asthma as preventative therapy in patients 5 years of age or older.

Important Safety Information
  • QVAR does not replace quick-relief inhalers for sudden symptoms
  • Do not use QVAR if you are allergic to beclomethasone dipropionate or any of the ingredients in QVAR
  • Do not use QVAR more often than it is prescribed. Do not stop taking QVAR abruptly without talking to your healthcare provider
  • QVAR may cause serious side effects, including:
    • Fungal infections (thrush). Tell your healthcare provider if you have any redness or white-colored patches in your mouth or throat. Rinse your mouth with water without swallowing after using QVAR to help prevent an infection in your mouth or throat
    • Worsening asthma or sudden asthma attacks. After using your rescue inhaler, contact your healthcare provider right away if you do not get relief from your sudden asthma attacks
    • Reduced adrenal function. This potentially life-threatening condition can happen when you stop taking oral corticosteroid medicines and start using QVAR. Tell your healthcare provider right away about any symptoms such as: tiredness, weakness, nausea and vomiting, and dizziness or faintness
    • Immune system effects or infection. Tell your healthcare provider about any signs or symptoms, such as: fever, pain, body aches, chills, feeling tired, nausea, or vomiting
    • Increased wheezing right after QVAR use. Always have a rescue inhaler with you to treat sudden wheezing
    • Serious allergic reactions. Stop using QVAR and call your healthcare provider or get emergency medical help right away if you get any of the following: hives; swelling of your lips, tongue, or face; rash; or breathing problems
    • Slowed growth in children. Children should have their growth checked regularly while using QVAR
    • Lower bone density. This may be a problem for people who already have a higher chance for this condition
    • Eye problems. If you have had glaucoma, cataracts or blurred vision in the past, you should have regular eye exams while using QVAR
  • The most common side effects of QVAR include: headache, throat irritation, and sinus irritation

  • Please see full Prescribing Information

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088.
  1. NHLBI Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma. Available at: Accessed July 27, 2015.